Literature DB >> 1645586

Steroids and depression.

B E Murphy1.   

Abstract

Patients with endogenous depression (major affective disorder) frequently have high cortisol levels, but the diurnal rhythm is usually maintained and they do not develop the physical signs of Cushing's syndrome. On the other hand, depression is a frequent feature of Cushing's syndrome regardless of etiology, and it is often relieved when the cortisol levels are reduced, by whatever means. The mechanisms of the hypercortisolemia and resistance to dexamethasone suppression commonly found in endogenous depression are poorly understood; contrary to expectations, ACTH levels are not clearly elevated. There is a striking difference in the psychiatric features seen in endogenous hypercorticism compared to those seen after exogenous administration of glucocorticoids or ACTH. This suggests that either there are other stimulating or modifying factors besides ACTH or that the steroids stimulated by ACTH or other peptides differ from those in control subjects, i.e. there may be an alteration in the metabolism of steroids in depression. Little is known about the metabolic changes or the many steroids besides glucocorticoids produced by the hyperactive steroid-producing tissue. Preliminary studies suggest that major depression may be improved by steroid suppression. It is hypothesized that steroids themselves may be important in causing and perpetuating depression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645586     DOI: 10.1016/0960-0760(91)90312-s

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  40 in total

1.  Enhancement of serotonin uptake by cortisol: a possible link between stress and depression.

Authors:  G E Tafet; M Toister-Achituv; M Shinitzky
Journal:  Cogn Affect Behav Neurosci       Date:  2001-03       Impact factor: 3.282

2.  Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium.

Authors:  M B Williams; R S Jope
Journal:  Psychopharmacology (Berl)       Date:  1995-12       Impact factor: 4.530

3.  Clomipramine in vitro reduces glucocorticoid receptor function in healthy subjects but not in patients with major depression.

Authors:  Livia A Carvalho; Mario F Juruena; Andrew S Papadopoulos; Lucia Poon; Rob Kerwin; Anthony J Cleare; Carmine M Pariante
Journal:  Neuropsychopharmacology       Date:  2008-03-26       Impact factor: 7.853

4.  Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.

Authors:  B E Murphy; D Filipini; A M Ghadirian
Journal:  J Psychiatry Neurosci       Date:  1993-11       Impact factor: 6.186

5.  Regulation of corticosteroid receptor gene expression in depression and antidepressant action.

Authors:  N Barden
Journal:  J Psychiatry Neurosci       Date:  1999-01       Impact factor: 6.186

6.  The role of Akt/FoxO3a in the protective effect of venlafaxine against corticosterone-induced cell death in PC12 cells.

Authors:  Haitao Wang; Xuanhe Zhou; Jianchu Huang; Nan Mu; Zeli Guo; Qiang Wen; Rikang Wang; Shaorui Chen; Zhong-Ping Feng; Wenhua Zheng
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

7.  Depressive symptoms, bone loss, and fractures in postmenopausal women.

Authors:  Leslie Spangler; Delia Scholes; Robert L Brunner; John Robbins; Susan D Reed; Katherine M Newton; Jennifer L Melville; Andrea Z Lacroix
Journal:  J Gen Intern Med       Date:  2008-02-20       Impact factor: 5.128

8.  Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients.

Authors:  Richard J Porter; Peter Gallagher; Stuart Watson; Margaret S Smith; Allan H Young
Journal:  Psychopharmacology (Berl)       Date:  2003-05-01       Impact factor: 4.530

Review 9.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

10.  Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.

Authors:  W Rostène; A Sarrieau; A Nicot; V Scarceriaux; C Betancur; D Gully; M Meaney; W Rowe; R De Kloet; D Pelaprat
Journal:  J Psychiatry Neurosci       Date:  1995-11       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.